New for old? Risperidone long-acting injection in older patients.
OBJECTIVE
To describe six older patients who were treated with risperidone long-acting injection, and to discuss the role of this medication in a psychogeriatric setting.


METHODS
Case series.


RESULTS
Of the six patients trialled on risperidone long-acting injection, two remain on this treatment. Of the other four, three required a change of treatment due to a combination of adverse side-effects and non-response, and one due to adverse side-effects alone.


CONCLUSIONS
Risperidone long-acting injection may have a role to play in the management of older patients with psychotic disorders but further research is required.
Hudson-Jessop
Pamela
P
Nambour Hospital, Nambour, Qld, Australia. pamela_hudson-jessop@health.qld.gov.au
Hughes
Brendan
B
Brinkley
Neridah
N
D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000453:epidemiology; D003692:Delayed-Action Preparations / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D018967:Risperidone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012720:Severity of Illness Index
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018967:Risperidone